Technical Analysis for NEO - NeoGenomics, Inc.

Grade Last Price % Change Price Change
grade B 23.9 2.97% 0.69
NEO closed up 2.97 percent on Wednesday, July 17, 2019, on approximately normal volume.

Earnings due: Jul 30

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical NEO trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Up 3 Days in a Row Strength 0.00%
Crossed Above 20 DMA Bullish 2.97%
Crossed Above 50 DMA Bullish 2.97%
Expansion Pivot Buy Setup Bullish Swing Setup 2.97%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.97%
Outside Day Range Expansion 2.97%
50 DMA Resistance Bearish 6.98%
NR7 Range Contraction 6.98%

Older signals for NEO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company's trademarks include NeoFISH, NeoFlow, NeoSITE, NeoArray, NeoType, and MelanoSITE. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Cancer Biology Diseases Genetics Lymphoma Medical Tests Leukemia Anatomical Pathology Laboratory Techniques Bladder Cancer Solid Tumor Cancers Hybridization Cytogenetics Fluorescence In Situ Hybridization
Is NEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.84
52 Week Low 11.05
Average Volume 946,400
200-Day Moving Average 18.3561
50-Day Moving Average 22.612
20-Day Moving Average 22.7985
10-Day Moving Average 22.938
Average True Range 0.8485
ADX 15.28
+DI 30.7762
-DI 17.4364
Chandelier Exit (Long, 3 ATRs ) 22.2945
Chandelier Exit (Short, 3 ATRs ) 23.5555
Upper Bollinger Band 24.2607
Lower Bollinger Band 21.3363
Percent B (%b) 0.88
BandWidth 12.82716
MACD Line 0.1443
MACD Signal Line 0.0879
MACD Histogram 0.0564
Fundamentals Value
Market Cap 1.9 Billion
Num Shares 79.4 Million
EPS -0.33
Price-to-Earnings (P/E) Ratio -72.42
Price-to-Sales 2.72
Price-to-Book 4.01
PEG Ratio 3.28
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.73
Resistance 3 (R3) 24.65 24.30 24.59
Resistance 2 (R2) 24.30 24.09 24.34 24.54
Resistance 1 (R1) 24.10 23.96 24.20 24.18 24.50
Pivot Point 23.75 23.75 23.80 23.79 23.75
Support 1 (S1) 23.55 23.54 23.65 23.63 23.30
Support 2 (S2) 23.20 23.41 23.24 23.26
Support 3 (S3) 23.00 23.20 23.21
Support 4 (S4) 23.08